Skip to main content
. 2013 Oct;26(4):759–780. doi: 10.1128/CMR.00030-13

Fig 2.

Fig 2

MIC distributions for Gram-positive clinical isolates collected in Europe, North America, and South America in 2002, before the introduction of daptomycin for clinical use. (Based on data from reference 56.)